CVM
CEL-SCI Corporation · AMEX
- Sector Health Technology
- Industry Biotechnology
- Website cel-sci.com
- Employees(FY) -
- ISIN US1508376076
Performance
-15.89%
1W
-16.45%
1M
-45.73%
3M
-43.05%
6M
-53.31%
YTD
-52.96%
1Y
Profile
CEL-SCI Corporation, a clinical-stage biotechnology company, engages in the research and development of immune system therapy for the treatment of cancer and other diseases in the United States. The company's lead immunotherapy is Multikine, which has completed Phase 3 clinical trials for the potential treatment of certain head and neck cancers. It is also developing products based on its proprietary technology Ligand Epitope Antigen Presentation System (LEAPS) technology, a patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, parasitic infections, autoimmune conditions, allergies, transplantation rejections, and cancer. In addition, the company's product pipeline includes CEL-2000; CEL-4000; and CEL-5000, which are LEAPS-based product candidates in preclinical trials for the treatment of rheumatoid arthritis disease. CEL-SCI Corporation was incorporated in 1983 and is headquartered in Vienna, Virginia.
Technical Analysis of CVM 2024-05-10
Overview:
In analyzing the technical indicators for CVM over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive assessment of the stock's potential price movement. By examining these key factors, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analy...
Recent News & Updates
- 2024-05-15 21:08
Cel-Sci: Fiscal Q2 Earnings Snapshot(Yahoo Finance)
- 2024-05-15 21:00
- 2024-05-08 04:02
- 2024-05-07 21:00
- 2024-04-22 21:00
CEL-SCI Appoints Mario Gobbo to Its Board of Directors(Yahoo Finance)
- 2024-03-18 21:00
- 2024-03-05 19:45
CEL-SCI Corporation Issues Letter to Shareholders(Yahoo Finance)
- 2024-02-14 19:00
- 2024-02-14 04:11
Cel-Sci: Fiscal Q1 Earnings Snapshot(Yahoo Finance)
- 2024-02-12 23:00
- 2024-02-08 19:30
- 2024-02-05 20:00
- 2024-01-30 20:00
- 2023-12-21 19:00
- 2023-12-03 19:30
- 2023-11-20 03:15
- 2023-11-15 19:30
- 2023-11-08 19:52
12 Best Day Trading Stocks To Buy(Yahoo Finance)
- 2023-10-29 21:20
CEL-SCI Issues Letter to Shareholders(Yahoo Finance)
- 2023-10-23 20:00
- 2023-10-22 21:15
- 2023-10-18 20:00
- 2023-10-08 19:50
CVM: Regulatory Journey Accelerating(Yahoo Finance)
- 2023-10-04 20:45
- 2023-09-25 21:00
- 2023-08-10 20:07
Cel-Sci: Fiscal Q3 Earnings Snapshot(Yahoo Finance)
- 2023-08-10 20:00
- 2023-07-30 17:49
CVM: Model Revisions(Yahoo Finance)
- 2023-07-19 23:36
CEL-SCI Announces Closing of Public Offering(Yahoo Finance)
- 2023-07-17 09:23
CEL-SCI Announces Pricing of Public Offering(Yahoo Finance)
Page 1 of 4
previousnext